Myocarditis and Pericarditis After Vaccination for COVID-19.

Szczegóły

Tytuł:: Myocarditis and Pericarditis After Vaccination for COVID-19.
Autorzy:: Diaz GA; Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, Washington.
Parsons GT; Providence Research Network, Renton, Washington.
Gering SK; Medical Intensive Care Unit, Providence Regional Medical Center Everett, Everett, Washington.
Meier AR; Department of Infection Prevention and Control, Providence Regional Medical Center Everett, Everett, Washington.
Hutchinson IV; Office of Clinical Research, Providence Health and Services, Southern California Region, Los Angeles.
Robicsek A; Providence Research Network, Renton, Washington.
Źródło:: JAMA [JAMA] 2021 Sep 28; Vol. 326 (12), pp. 1210-1212.
Typ publikacji:: Journal Article; Multicenter Study
Język:: English
Imprint Name(s):: Original Publication: Chicago : American Medical Association, 1960-
MeSH Terms:: COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
Myocarditis/*etiology
Pericarditis/*etiology
2019-nCoV Vaccine mRNA-1273 ; Ad26COVS1 ; Adult ; Aged ; BNT162 Vaccine ; COVID-19 Vaccines/administration & dosage ; Confidence Intervals ; Female ; Hospitalization/statistics & numerical data ; Humans ; Incidence ; Los Angeles/epidemiology ; Male ; Middle Aged ; Montana/epidemiology ; Myocarditis/epidemiology ; Oregon/epidemiology ; Pericarditis/epidemiology ; Poisson Distribution ; Time Factors ; Washington/epidemiology
Substance Nomenclature:: JT2NS6183B (Ad26COVS1)
0 (COVID-19 Vaccines)
EPK39PL4R4 (2019-nCoV Vaccine mRNA-1273)
N38TVC63NU (BNT162 Vaccine)
Entry Date(s):: Date Created: 20210804 Date Completed: 20211006 Latest Revision: 20221207
Update Code:: 20240105
PubMed Central ID:: PMC8340007
DOI:: 10.1001/jama.2021.13443
PMID:: 34347001
: Czasopismo naukowe

Informacja